Highlights Eli Lilly and Company Xetra

Equities

Real-time Estimate Tradegate Other stock markets 15:30:33 17/07/2024 BST			5-day change	1st Jan Change
834.2 ^EUR	-4.36%		-4.23%	+57.82%

03:53pm	TD Cowen Raises Price Target on Eli Lilly to $1,050 From $850	MT
03:38pm	Earnings reports take center stage as tech stocks tumble

Earnings reports take center stage as tech stocks tumble	02:38pm
Wall Street set to fall as megacap chip, tech stocks tumble	02:14pm	RE
Roche reports positive early results in obesity drug trial	07:13am	RE
Aclaris Therapeutics Sells Olumiant Royalties, Milestone Payments From Eli Lilly	07-16	MT
Novo owner backs Swiss biotech Asceneuron in $100 million round	07-16	RE
Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market	07-12	RE
Ozempic linked with lower dementia risk, nicotine use, British study finds	07-12	RE
EU Drug Regulator Issues New Safety Measures for GLP-1 Drugs Amid Aspiration Risk Concerns	07-12	MT
Health Care Up as Obesity-Drug Wars Continue -- Health Care Roundup	07-11	DJ
Pfizer moves forward with once-daily weight loss drug	07-11	RE
DexCom, Inc. : A Must-Have Tool for Diabetes Care	07-10
Analysis Shows Use of Novo Nordisk's Wegovy, Ozempic for Weight Loss Declines After Two Years	07-10	MT
Sellers of fake Ozempic to face charges in Austrian court	07-09	RE
Mixed feelings	07-09
Eli Lilly's Mounjaro Provides Better Weight Loss Compared to Semaglutide-Based Drugs, Study Shows	07-09	MT
Novo Nordisk shares down after analysis finds Lilly drug leads to better weight loss	07-09	RE
Health Care Flat Amid Deal Activity -- Health Care Roundup	07-08	DJ
S&P 500, Nasdaq Extend Record Closing Runs	07-08	MT
S&P 500, Nasdaq Extend Record High Closing Runs	07-08	MT
US Equities Markets End Mixed as Investors Await Inflation Data	07-08	MT

No results for this search

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 06:47 pm